🟢 InnovAge is trading 9% up today after fiscal Q1 revenue and earnings beat

InnovAge is trading at $9.58, up 9.04%, after adjusted fiscal Q1 2027 earnings beat forecasts.

• Revenue was $264.8 million, up 12.1% year over year; adjusted earnings were $0.14 per share versus the $0.08 forecast.
• Adjusted EBITDA grew more than 75%, while census rose 6.7% to 8,420.
• Management reaffirmed fiscal 2027 revenue guidance of $1.05 billion–$1.085 billion; broader markets are also sharply higher.